ZP-6590

N/A

Report date: 2023/08/22 14:15:27

Base Information

Drug NameZP-6590
Drug Alias NameZP 6590ZP-6590
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesZealand Pharma A/S
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A